1. Maccari F., Ramacci M.T. (1981): Antagonism of doxorubicin cardiotoxicity by carnitine is specific of the L-diastereoisomer. Biomedicine, 35,65–67.
2. Pommier Y., Schwatrz R.E., Zelling L.A., Kohn K.W. (1985): Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei. Biochemistry, 24,6406–6410.
3. Massart C., Barbet R., Genetet N., Gibassier J. (2004): Doxorubicin Induces Fas-Mediated Apoptosis in Human Thyroid Carcinoma Cells. Thyroid, 14,263–270.
4. Wu X.X., Kakehi Y., Mizutani Y., Kamoto T., Kinoshita H., Isogawa Y., Terachi T., Ogawa O. (2002): Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer. Int. J. Oncol., 20, 949–954.
5. Wu X.X., Mizutani Y., Kakehi Y., Yoshida O., Ogawa O. (2000): Enhancement of Fas-mediated Apoptosis in Renal Cell Carcinoma Cells by Adriamycin. Cancer Res., 60,2912–2918.